C81.12

Clinical Causes: Genetic factors: Family history may increase risk. Immune system Issues: Conditions that weaken immunity might contribute. Infections: Epstein-Barr virus (EBV) has been associated with Hodgkin lymphoma. Environmental exposures: Certain chemical exposures may play a role. Other factors: Age and gender can influence susceptibility.

Key Symptoms: Swelling of lymph nodes in the chest area, which may cause a visible lump or discomfort. Persistent cough or shortness of breath due to pressure on airways. Chest pain or discomfort, often sharp or localized. Unexplained weight loss over recent months. Night sweats and recurrent fever. Fatigue and general weakness. Itchiness without an apparent cause.

Diagnosis Path: Physical examination to identify enlarged lymph nodes or other abnormalities. Imaging studies such as chest X-rays, CT scans, or PET scans to visualize lymph node involvement and assess extent. Lymph node biopsy: Removing tissue for microscopic examination to confirm Hodgkin lymphoma and identify its subtype. Blood tests to evaluate overall health and organ function. Bone marrow biopsy in some cases to check spread. Additional tests to determine specific markers or genetic features relevant to treatment planning.

Treatment Protocols: Chemotherapy: Drugs that destroy cancer cells, often involving regimens such as ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine). Radiation therapy: Targeted radiation beams to affected lymph nodes, used alone or in conjunction with chemotherapy. Immunotherapy: Medications that assist the immune system in fighting cancer, sometimes included in treatment plans. Stem cell transplant: Considered in cases of relapse or resistant disease. Supportive care: Managing side effects, maintaining nutrition, and addressing complications.